grant
saveALEUTIAN THERAPEUTICS, INC. — Development of an immune evasive stem cell line for Type 1 diabetes regenerat...
September 7, 2025updated 2mo ago
community read0 votes
DK grant. $372,067. PI: Christopher Shen
view source ↗DK grant. $372,067. PI: Christopher Shen
view source ↗
comments(0)
5-min edit window · permanent after that